Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab

Ustekinumab for the treatment of psoriasis is currently administered in a standard dosing regimen. However, some patients tend to benefit from alternative dosing regimens, a step toward personalized medicine. METHODS: To investigate the role of ustekinumab serum concentrations, anti-ustekinumab anti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ther Drug Monit
Hauptverfasser: De Keyser, Eline, Busard, Celine I., Lanssens, Sven, Meuleman, Lieve, Hutten, Barbara A., Costanzo, Antonio, van den Reek, Juul M., Zweegers, Jeffrey, Lambert, Jo, Spuls, Phyllis I.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Therapeutic Drug Monitoring 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6752798/
https://ncbi.nlm.nih.gov/pubmed/31107404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000646
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge